4//SEC Filing
Bozic Carmen 4
Accession 0000875320-24-000024
CIK 0000875320other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 4:33 PM ET
Size
8.2 KB
Accession
0000875320-24-000024
Insider Transaction Report
Form 4
Bozic Carmen
EVP and CMO
Transactions
- Award
Common Stock
2024-02-06+5,814→ 35,116 total - Award
Common Stock
2024-02-07+5,928→ 48,910 total - Award
Common Stock
2024-02-06+7,866→ 42,982 total
Footnotes (3)
- [F1]Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2021 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest on 02/20/2024.
- [F2]Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2023 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest in installments beginning on 02/10/2024.
- [F3]Restricted stock unit award that vests in installments beginning on 02/17/2025.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001790029
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 4:33 PM ET
- Size
- 8.2 KB